Hybrid nanovaccine for the co-delivery of the mRNA antigen and adjuvant.
Sign Up to like & getrecommendations! Published in 2019 at "Nanoscale"
DOI: 10.1039/c9nr05475h
Abstract: For efficient cancer vaccines, the antitumor function largely relies on cytotoxic T cells, whose activation can be effectively induced via antigen-encoding mRNA, making mRNA-based cancer vaccines an attractive approach for personalized cancer therapy. While the… read more here.
Keywords: delivery mrna; delivery; antigen; hybrid nanovaccine ... See more keywords